Citations for
1AKAP12
Gravin is a transitory effector of polo-like kinase 1 during cell division.
Canton DA, Keene CD, Swinney K, Langeberg LK, Nguyen V, Pelletier L, Pawson T, Wordeman L, Stella N, Scott JD.
Mol Cell 48(4):547-59. doi: 10.1016/j.molcel.2012.09.002. Epub 2012 Oct 11. 2012
2AKAP12
Pivotal Role of AKAP12 in the Regulation of Cellular Adhesion Dynamics: Control of Cytoskeletal Architecture, Cell Migration, and Mitogenic Signaling.
Akakura S, Gelman IH.
J Signal Transduct 2012:529179. doi: 10.1155/2012/529179. Epub 2012 Jun 28. 2012
3AKAP12
Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.
Gelman IH.
Cancer Metastasis Rev 31(3-4):493-500. doi: 10.1007/s10555-012-9360-1. Review. 2012
4AKAP12, HDAC7
The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells.
Turtoi A, Mottet D, Matheus N, Dumont B, Peixoto P, Hennequière V, Deroanne C, Colige A, De Pauw E, Bellahcène A, Castronovo V.
Angiogenesis 15(4):543-54. doi: 10.1007/s10456-012-9279-8. Epub 2012 May 15. 2012
5AKAP12
Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M, Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Takeda S, Kodera Y.
J Surg Oncol 105(4):381-6. doi: 10.1002/jso.22135. Epub 2011 Nov 3. 2012
6AKAP12, AKAP5
AKAP12 and AKAP5 form higher-order hetero-oligomers.
Gao S, Wang HY, Malbon CC.
J Mol Signal 6:8. doi: 10.1186/1750-2187-6-8. 2011
7AKAP12, AKAP5
AKAP5 and AKAP12 Form Homo-oligomers.
Gao S, Wang HY, Malbon CC.
J Mol Signal 6:3. doi: 10.1186/1750-2187-6-3. 2011
8AKAP12
AKAR2-AKAP12 fusion protein "biosenses" dynamic phosphorylation and localization of a GPCR-based scaffold.
Tao J, Wang HY, Malbon CC.
J Mol Signal 5:3. doi: 10.1186/1750-2187-5-3. 2010
9AKAP12
Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer.
Liu W, Guan M, Su B, Li J, Ma W, Liu C, Li M, Lin Y, Lu Y.
Clin Chim Acta 411(13-14):940-6. doi: 10.1016/j.cca.2010.03.003. Epub 2010 Mar 11. 2010
10AKAP12
SSeCKS promotes tumor necrosis factor-alpha autocrine via activating p38 and JNK pathways in Schwann cells.
Zhou Z, Tao T, Ji Y, Yang H, Wang Y, Cheng C, Shen A, Lu X.
Cell Mol Neurobiol 30(5):701-7. doi: 10.1007/s10571-009-9494-z. Epub 2010 Jan 29. 2010
11AKAP12
SSeCKS is a suppressor in Schwann cell differentiation and myelination.
Ji Y, Tao T, Cheng C, Yang H, Wang Y, Yang J, Liu H, He X, Wang H, Shen A.
Neurochem Res 35(2):219-26. doi: 10.1007/s11064-009-0045-2. Epub 2009 Sep 16. 2010
12AKAP12, AKAP5
G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential trafficking and distribution.
Chen MH, Malbon CC.
Cell Signal 21(1):136-42. Epub 2008 Oct 10. 2009
13AKAP12, PRKACA
Gravin dynamics regulates the subcellular distribution of PKA.
Yan X, Walkiewicz M, Carlson J, Leiphon L, Grove B.
Exp Cell Res 315(7):1247-59. Epub 2009 Jan 13. 2009
14AKAP12
A-kinase anchoring protein 12 regulates the completion of cytokinesis.
Choi MC, Lee YU, Kim SH, Park JH, Kim HA, Oh DY, Im SA, Kim TY, Jong HS, Bang YJ.
Biochem Biophys Res Commun 373(1):85-9. Epub 2008 Jun 11. 2008
15AKAP12
AKAP12 in astrocytes induces barrier functions in human endothelial cells through protein kinase Czeta.
Choi YK, Kim KW.
FEBS J 275(9):2338-53. Epub 2008 Apr 3. 2008
16AKAP12
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
Jin Z, Hamilton JP, Yang J, Mori Y, Olaru A, Sato F, Ito T, Kan T, Cheng Y, Paun B, David S, Beer DG, Agarwal R, Abraham JM, Meltzer SJ.
Cancer Epidemiol Biomarkers Prev 17(1):111-7. 2008
17AKAP12
AKAP12 regulates human blood-retinal barrier formation by downregulation of hypoxia-inducible factor-1alpha.
Choi YK, Kim JH, Kim WJ, Lee HY, Park JA, Lee SW, Yoon DK, Kim HH, Chung H, Yu YS, Kim KW.
J Neurosci 27(16):4472-81. 2007
18AKAP12
Gravin gene expression in acute leukaemias: clinical importance and review of the literature.
Yildirim M, Paydas S, Tanriverdi K, Seydaoglu G, Disel U, Yavuz S.
Leuk Lymphoma 48(6):1167-72. Review. 2007
19AKAP12
AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.
Flotho C, Paulun A, Batz C, Niemeyer CM.
Br J Haematol 138(5):644-50. 2007
20AKAP12
An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics.
Willoughby D, Wong W, Schaack J, Scott JD, Cooper DM.
EMBO J 25(10):2051-61. Epub 2006 Apr 27. 2006
21AKAP5, AKAP12
G-Protein-coupled receptor-associated A-kinase anchoring proteins: AKAP79 and AKAP250 (gravin).
Wang HY, Tao J, Shumay E, Malbon CC.
Eur J Cell Biol 85(7):643-50. Epub 2006 Jan 26. Review. 2006
22AKAP12
Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles.
Streb JW, Kitchen CM, Gelman IH, Miano JM.
J Biol Chem 279(53):56014-23. Epub 2004 Oct 20. 2004
23AKAP12
Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein.
Nauert JB, et al.
Curr Biol 7(1):52-62 1997
24AKAP12
Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera.
Gordon T, et al.
J Clin Invest 90(3):992-9 1992